Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Levine

Showing results (1-10 of 160) with videos related to

Pageof 16
Sort By:
Science'S STKE : Signal Transduction Knowledge Environment|May 4, 2006
Where do you think you are going? The NMDA-D1 receptor trapCarlos Cepeda, Michael S Levine
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
Dual regulation by the Hunchback gradient in the Drosophila embryoDmitri Papatsenko, Michael S Levine
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|November 17, 2020
Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal ModelsCarlos Cepeda, Michael S Levine
Science Advances|May 13, 2026
A thyroid hormone-mediated opsin switch initiates metamorphosis in a proto-vertebrateAndrea Mariossi, Michael S Levine
Neuron|May 15, 2012
2B or not 2B: a tail of two NMDA receptor subunitsCarlos Cepeda, Michael S Levine
Current Opinion in Genetics & Development|November 17, 2020
Enhancer-promoter communication: hubs or loops?Bomyi Lim, Michael S Levine
Journal of Neurophysiology|September 17, 2004
Age-dependent biphasic changes in ischemic sensitivity in the striatum of Huntington's disease R6/2 transgenic miceGloria J Klapstein, Michael S Levine
Developmental Neuroscience|May 9, 2006
Changes in expression of N-methyl-D-aspartate receptor subunits occur early in the R6/2 mouse model of Huntington's diseaseNoore J Ali, Michael S Levine
Proceedings of the National Academy of Sciences of the United States of America|December 24, 2008
Properties of developmental gene regulatory networksEric H Davidson, Michael S Levine
Future Neurology|April 21, 2015
Evidence from the R6/2 Mouse Model of Huntington's Disease for Using Abnormal Brain Metabolism as a Biomarker for Evaluating Therapeutic Approaches for TreatmentAnna Parievsky, Carlos Cepeda, Michael S Levine
Pageof 16

Showing results (1-10 of 160) with videos related to

Sort By:
Pageof 16
Science'S STKE : Signal Transduction Knowledge Environment|May 4, 2006
Where do you think you are going? The NMDA-D1 receptor trapCarlos Cepeda, Michael S Levine
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
Dual regulation by the Hunchback gradient in the Drosophila embryoDmitri Papatsenko, Michael S Levine
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|November 17, 2020
Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal ModelsCarlos Cepeda, Michael S Levine
Science Advances|May 13, 2026
A thyroid hormone-mediated opsin switch initiates metamorphosis in a proto-vertebrateAndrea Mariossi, Michael S Levine
Neuron|May 15, 2012
2B or not 2B: a tail of two NMDA receptor subunitsCarlos Cepeda, Michael S Levine
Current Opinion in Genetics & Development|November 17, 2020
Enhancer-promoter communication: hubs or loops?Bomyi Lim, Michael S Levine
Journal of Neurophysiology|September 17, 2004
Age-dependent biphasic changes in ischemic sensitivity in the striatum of Huntington's disease R6/2 transgenic miceGloria J Klapstein, Michael S Levine
Developmental Neuroscience|May 9, 2006
Changes in expression of N-methyl-D-aspartate receptor subunits occur early in the R6/2 mouse model of Huntington's diseaseNoore J Ali, Michael S Levine
Proceedings of the National Academy of Sciences of the United States of America|December 24, 2008
Properties of developmental gene regulatory networksEric H Davidson, Michael S Levine
Future Neurology|April 21, 2015
Evidence from the R6/2 Mouse Model of Huntington's Disease for Using Abnormal Brain Metabolism as a Biomarker for Evaluating Therapeutic Approaches for TreatmentAnna Parievsky, Carlos Cepeda, Michael S Levine
Pageof 16